Skip to main content
OpenTrials

Clinical trial condition

Lupus Nephritis

Explore clinical trials studying Lupus Nephritis. Study availability and eligibility vary by location and protocol.

155 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Lupus Nephritis trial results

Recruiting

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

NCT07598396

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Clnica SER da Bahia Salvador, Estado de Bahia, Brazil
  • L2IP ?Instituto de Pesquisas Clínicas Ltda. Brasília, Federal District, Brazil
  • IPC MT Instituto de Pesquisas Clinicas do Mato Grosso Cuiab, Mato Grosso, Brazil
  • Complexo Hospitalar de Niteroi Niterói, Rio de Janeiro, Brazil
View all 17 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Vitória, Espírito Santo, Brazil
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
View all 41 locations
View Trial Details
Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

NCT07053800

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • State University of New York Upstate Medical Center (SUNY) Syracuse, New York, United States
  • Texas Transplant Institute San Antonio, Texas, United States
  • University General Hospital ATTIKON Athens, Greece
  • University General Hospital of Patras Pátrai, Greece
View Trial Details
Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

NCT06527872

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Columbus, Ohio, United States
  • GSK Investigational Site Hixson, Tennessee, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Loma Linda University health Loma Linda, California, United States
  • UCSF Benioff Childrens Hospital San Francisco, California, United States
  • Children's Hospital Colorado, Anchutz Medical Campus Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
View all 42 locations
View Trial Details
Recruiting

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

NCT07015983

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Local Institution - 0106 Phoenix, Arizona, United States
  • Local Institution - 0038 Los Angeles, California, United States
  • Local Institution - 0051 Los Angeles, California, United States
  • Local Institution - 0093 Newport Beach, California, United States
View all 96 locations
View Trial Details

Related conditions